COAST-1

2 stories · following the connections

Business

Axsome Announces CREATE-1 Interim Analysis Expected Year-End 2017

By Nasdaq OMXSep 7, 2017, 11:00 AM UTC

Business

Axsome Therapeutics Initiates Phase 3 Study of AXS-02 for Knee Osteoarthritis Associated with Bone Marrow Lesions

By Nasdaq OMXMar 28, 2016, 11:00 AM UTC